The antitumor activity of a novel ansamycin antibiotic, trienomycin A, against various murine tumors was studied with two treatment schedules. The intraperitoneal injection of the antibiotic showedremarkable antitumor activity on sarcoma180 and P388leukemia at doses of 160 or 320 mg/kg, showing 151 %and 100% increase in life span, respectively.
The antitumor activity of a novel ansamycin antibiotic, trienomycin A, against various murine tumors was studied with two treatment schedules. The intraperitoneal injection of the antibiotic showedremarkable antitumor activity on sarcoma180 and P388leukemia at doses of 160 or 320 mg/kg, showing 151 %and 100% increase in life span, respectively.
Trienomycin Ainhibited the growth of Ehrlich and Meth A cells in vitro at doses of 0.10 .4 //g/ml when the cells were exposed to the antibiotic for 72 hours. The incorporation of [3H]thymidine into acid precipitable material in HeLacells was slightly more marked than that of [3H]uridine and [3H]leucine whenthe cells were exposed to 0.04 or 0.08^g/ml of trienomycin A for 4 hours. It appeared that trienomycin A showed antitumor activity by direct cytotoxic action.
Trienomycin A, a novel ansamycin antibiotic, was first reported by Umezawaet al. as a cytocidal antibiotic^. Trienomycin A is unique among the benzenoid ansamycin antibiotics in that it does not have a^-quinone or^-hydroquinone moiety in the structure^. The benzenoid moiety of trienomycin A is somewhat similar to that of maytansinoids derived from plant materials50.
Thereafter, two other fractions, trienomycins B and C, were isolated from the same fermentation broth4). Amongthe trienomycins, substance A showed remarkable cytocidal activity against HeLa cells in vitro. The experiments reported herein were designed mainly to elucidate the antitumor activity of trienomycin A on transplantable murine tumors.
Materials and Methods

Animals
Female ICR, ddY, CDFXand C57BL/6 mice, 6 weeks of age, were purchased from the Shizuoka Laboratory Animal Center (Hamamatsu, Japan).
Agents
Trienomycin A was isolated and purified according to the some procedure reported previously1}. Trienomycin A was dissolved in a small amount of MeOHand Tween80, diluted with saline and injected intraperitoneally into tumor bearing mice. TumorCell Lines and Antitumor Activity Tumorcells were maintained by weekly passage intraperitoneally in mice. Tumorcell lines and mice used are listed in Table 1 . Antitumor activity was evaluated by the increase in life span (ILS): (T/C-l) x 1QO(%), where "T" is the mean survival days (MSD) of the treated group and "C" is the MSDof the control group. Survival of the mice was scored 60 days after inoculation of tumors, and mice remaining alive after this period of observation were considered cured.
Cytotoxicity for Tumor Cells
Ehrlich and Meth A tumor cells were maintained in RPMI1640 mediumsupplemented with 10% fetal bovine serum and kanamycin (50 jug/ml) at 37°C. To determine the cytotoxicity of trienomycin A, Ehrlich cells (7.5xlO4) or Meth A cells (3.8xlO4) in 1.5 ml of medium were placed in a tissue culture plate (Falcon, 24 wells) and incubated for 48 hours at 37°C in a 5-% CO2-95%air atmosphere. To each culture well was added 0.5 ml of fresh mediumcontaining a different concentration of trienomycin A, and they were reincubated. After further 72 hours of incubation the cells were counted by a hemocytometer.
Measurement of Macromolecular Synthesis HeLa cells (5 x 104/0.2 ml) were plated on a cover slip (LUX, 13 mmi.d.) inserted previously into a tissue culture plate (Falcon, 24 wells), and 2 ml of minimum essential medium was added after 3 hours. Following 48 hours of incubation, each culture well was refilled with fresh medium containing a different concentration of the antibiotic. The cells were exposed to trienomycin A for 1 and 4 hours. One hour before termination of the culture, various precursors were added. At the end of the incubation period, cells were washed once with ice-cold phosphate buffered saline, and three times with icecold 5% TCA.The radioactivity of acid-precipitable material on the cover slip was measured by an Aloka liquid scintillation spectrometer.
Results
Cytotoxicity
for Tumor Cells Cytotoxic activity of trienomycin A was determined on Ehrlich carcinoma cells and Meth A fibrosarcoma cells in vitro. Whenthe cells were exposed to trienomycin A for 72 hours, cell growth was remarkably suppressed at a dose of 0.4 #g/ml (Table 2) . MICwas determined by the conventional serial dilution method using potato -glucose agar. leukemia and IMC carcinoma. Only a slight life prolongation effect was observed on Lewis lung carcinoma and B16 melanoma by the 10-day or the 5-day treatment schedules, respectively ( When HeLa cells were exposed to 0.008~0.2 /^g/ml of the antibiotic for 4 hours, the incorporation of [3H]TdRinto acid precipitable material was slightly more marked than that of the other two precursors at lower concentrations of the antibiotic (Fig. 1) .
Discussion
As shown in this study, trienomycin A possessed antitumor activity against murine tumors. The antibiotic also inhibited the growth of mammalian cells at doses of 0.4~0.1 /^g/ml, whereas the growth inhibition of bacteria was weak as shown in the previous paper (paper-disk method)0 and in Table 4 (agar dilution method). Amongseveral ansamycin antibiotics, mycotrienins I and II are similar to trienomycin A in structure5}. However, mycotrienins did not show definite anti-P388 activity in vivo in contrast to antifungal activity in vitro6). The structure of trienomycin Ais unique amongbenzenoid ansamycin antibiotics in that the antibiotic does not have a^-quinone or^-hydroquinone moiety in its structure. This unique structure could be important because it possesses antitumor activity instead of antifungal activity. Cytotoxicity was decreased when the triene moiety of trienomycin A was reduced by catalytic hydrogenation (data not shown). This fact indicated that the triene moiety is essential for the activity of trienomycin A.
Inhibition of incorporation of [3H]TdRinto acid precipitable materials of mammaliancells was relatively more marked than that of the other two precursors. However, no definite characteristic was observed in the present brief experiment. Weare now investigating the mechanismof action of this antibiotic, and the results will be reported elsewhere.
